These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23011962)

  • 1. Treatment strategies to overcome end-of-dose failure with oral and transdermal opioids.
    Hall LM; O'Lenic K
    J Pharm Pract; 2012 Oct; 25(5):503-9. PubMed ID: 23011962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.
    Nicholson B
    Postgrad Med; 2013 Jan; 125(1):115-27. PubMed ID: 23391677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids for chronic noncancer pain: still no evidence for superiority of sustained-release opioids.
    Pedersen L; Fredheim O
    Clin Pharmacol Ther; 2015 Feb; 97(2):114-5. PubMed ID: 25670511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.
    Mercadante S
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):460-5. PubMed ID: 21215653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational opioid dosing in the elderly: dose and dosing interval when initiating opioid therapy.
    Gupta DK; Avram MJ
    Clin Pharmacol Ther; 2012 Feb; 91(2):339-43. PubMed ID: 22205194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
    Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
    Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative management of the child on long-term opioids.
    Geary T; Negus A; Anderson BJ; Zernikow B
    Paediatr Anaesth; 2012 Mar; 22(3):189-202. PubMed ID: 22098293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of extended-release opioid analgesics for the treatment of chronic pain.
    Gudin JA
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):49-61. PubMed ID: 23527669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-of-dose pain in chronic pain: does it vary with the use of different long-acting opioids?
    Zimmermann M; Richarz U
    Pain Pract; 2014 Nov; 14(8):757-69. PubMed ID: 24373184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in opioid prescription for chronic non-cancer pain.
    Snidvongs S; Mehta V
    Postgrad Med J; 2012 Feb; 88(1036):66-72. PubMed ID: 21725034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid rotation in clinical practice.
    Nalamachu SR
    Adv Ther; 2012 Oct; 29(10):849-63. PubMed ID: 23054690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.
    Mercadante S; Gatti A; Porzio G; Lo Presti C; Aielli F; Adile C; Casuccio A
    Curr Med Res Opin; 2012 Jun; 28(6):963-8. PubMed ID: 22480130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects and challenges in opioid analgesia for pain management.
    Mercadante S
    Curr Med Res Opin; 2011 Sep; 27(9):1741-3. PubMed ID: 21770715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific pharmacology of long-acting, extended-release, and sustained-release opioids for the treatment of chronic nonmalignant pain.
    Sloan PA; Davis MP; Gamier P
    J Opioid Manag; 2015; Suppl():21-41. PubMed ID: 25539290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.